Skip to main content
See every side of every news story
Published loading...Updated

PRESS RELEASE: Admaius Capital Partners Announces Successful Exit From Parkville Pharmaceuticals

25 January 2026 Cairo, Egypt – Admaius Capital Partners (“Admaius”), a market-leading pan-African private equity firm, along with Dr. Sherif Bassiouny, Chairman of Parkville Pharmaceuticals (“Parkville”), and Dr. Mahmoud Farrag, CEO of Parkville, has signed definitive agreements to sell a majority stake in Parkville to Adenia Partners (“Adenia”). The transaction is subject to customary closing conditions and regulatory approvals. Financial terms…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

4 Articles

In cooperation with Dr. Sharif Bassiouni, Chairman of the Board of Directors of Parkville Pharmaceuticals, and Dr. Mahmoud Faraj, CEO of the Company, the leading direct investment in Africa, announced that final agreements had been signed for the sale of a majority interest in Parkville to Adinia Partners.

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

alalamelyoum.co broke the news in on Monday, January 26, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal